Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Tango Therapeutics (NASDAQ: TNGX), a clinical-stage biotech company specializing in precision cancer medicines, announced that CEO Barbara Weber, M.D., will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, at 2:40 PM ET. The presentation will be webcast live on the company's website under the 'Events & Presentations' tab on the 'Investors' page, and a replay will be available for 90 days post-event.

Positive

• CEO Barbara Weber, M.D., presenting at a high-profile conference could increase visibility and credibility for Tango Therapeutics.
• The live webcast and 90-day replay availability provide extended access for potential investors and stakeholders.
• Participation in the Goldman Sachs Global Healthcare Conference indicates recognition and integration within the healthcare investment community.

Negative

• The announcement lacks specific financial or clinical data updates that investors might be looking for.
• No mention of any new product developments, trial results, or strategic partnerships may disappoint some investors.
• Potential for increased costs related to conference participation without immediate, tangible ROI.

BOSTON--(BUSINESS WIRE)-- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to present at the Goldman Sachs 45^th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 2:40 PM ET.

A live webcast of the presentation will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240605891914/en/

Investor Contact:

Sam Martin/Andrew Vulis

Argot Partners

tango@argotpartners.com

Media Contact:

Amanda Galgay

SVP, Corporate Communications, Tango Therapeutics

media@tangotx.com

Source: Tango Therapeutics, Inc.

FAQ

When and where is Tango Therapeutics presenting at the Goldman Sachs conference?

Tango Therapeutics will present on June 11, 2024, at 2:40 PM ET at the Goldman Sachs 45th Annual Global Healthcare Conference.

How can I watch the Tango Therapeutics presentation at the Goldman Sachs conference?

You can watch the live webcast on Tango Therapeutics' website under the 'Events & Presentations' tab on the 'Investors' page.

Will there be a replay available for Tango Therapeutics' presentation?

Yes, a replay of the webcast will be available on Tango Therapeutics' website for 90 days following the presentation.